BRIM Biotechnology, Inc. (TPE:6885)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
20.35
-0.35 (-1.69%)
Jul 30, 2026, 1:30 PM CST

BRIM Biotechnology Balance Sheet

Millions TWD. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
283.63798.43502.76948837.99399.75
Short-Term Investments
784.083601,346747.63-23.84
Cash & Short-Term Investments
1,0681,1581,8491,696837.99423.59
Cash Growth
-40.44%-37.34%9.03%102.34%97.83%149.98%
Accounts Receivable
0.650.63----
Other Receivables
4341.8223.366.240.450.37
Receivables
43.6642.4623.366.240.450.37
Inventory
0.580.67----
Prepaid Expenses
10.816.994.0711.110.556.65
Other Current Assets
0.70.140---
Total Current Assets
1,1231,2091,8761,713848.99430.61
Property, Plant & Equipment
13.4514.5111.796.377.993.62
Long-Term Investments
19.5923.5538.2757.382.3360.35
Goodwill
67.5667.56----
Other Intangible Assets
502.75512.06483.391.340.09-
Other Long-Term Assets
1.361.371.020.70.590.86
Total Assets
1,7281,8282,4111,779939.99495.44

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
0.950.85----
Accrued Expenses
25.5647.3615.5236.0416.9912.34
Current Portion of Long-Term Debt
2.672.97----
Current Portion of Leases
4.655.844.233.483.632.85
Current Unearned Revenue
2.120.83----
Other Current Liabilities
5.159.09331.082.521.872.05
Total Current Liabilities
41.1166.94350.8442.0522.4817.23
Long-Term Debt
5.976.46----
Long-Term Leases
0.030.683.540.112.810.32
Total Liabilities
47.1174.08354.3842.1625.317.55

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
1,3301,3321,3151,158932.54692.54
Additional Paid-In Capital
1,1371,3641,6361,725589.72454.31
Retained Earnings
-1,086-1,021-884.69-1,149-771.19-746.92
Comprehensive Income & Other
212.7-20.38-9.852.95163.6377.96
Total Common Equity
1,5931,6552,0561,737914.69477.89
Minority Interest
87.9698.64----
Shareholders' Equity
1,6811,7542,0561,737914.69477.89
Total Liabilities & Equity
1,7281,8282,4111,779939.99495.44

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
13.3215.967.783.596.443.16
Net Cash (Debt)
1,0541,1421,8411,692831.55420.42
Net Cash Growth
-40.97%-37.94%8.80%103.48%97.79%157.57%
Net Cash Per Share
8.038.6915.7816.8311.667.09
Filing Date Shares Outstanding
133.02133.21131.5115.7593.2569.25
Total Common Shares Outstanding
133.02133.21131.5115.7593.2569.25
Working Capital
1,0821,1421,5251,671826.51413.38
Book Value Per Share
11.9812.4215.6415.009.816.90
Tangible Book Value
1,0231,0751,5731,735914.6477.89
Tangible Book Value Per Share
7.698.0711.9614.999.816.90
Machinery
17.5615.999.126.464.843.59
Leasehold Improvements
3.783.673.673.443.193.07